Document is current

Any future updates will be listed below

Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy

Crossref DOI link: https://doi.org/10.1186/s12957-023-02931-z

Published Online: 2023-02-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark